News of Note—Chickenpox outbreak, GeoVax and more

newspaper
In this week's news of note, GeoVax entered a new immunotherapy collaboration. (Pixabay)

Here is some other vaccine news of note for the week:

> A chickenpox outbreak in a North Carolina anti-vaccination hotbed is the state's worst in two decades. The Washington Post article

> GeoVax entered a collaboration with Leidos to test its vaccine candidates in conjunction with Leidos-developed checkpoint inhibitors. Release

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

> In a preclinical study, a DNA vaccine lowered the buildup of tau and beta-amyloid proteins associated with Alzheimer's disease. Release

Read more on

Suggested Articles

An FDA panel gave Sanofi's Dengvaxia a mixed endorsement, voting down its use in people 17 and older.

Prosecutors in the Philippines have found probable cause to indict six Sanofi officials for its Dengvaxia rollout.

The FDA has issued guidance on continuous manufacturing and is allocating $58 million to move forward advanced manufacturing processes.